319 related articles for article (PubMed ID: 20144424)
1. Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.
Wilinska ME; Budiman ES; Taub MB; Elleri D; Allen JM; Acerini CL; Dunger DB; Hovorka R
J Diabetes Sci Technol; 2009 Sep; 3(5):1109-20. PubMed ID: 20144424
[TBL] [Abstract][Full Text] [Related]
2. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
[TBL] [Abstract][Full Text] [Related]
3. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
[TBL] [Abstract][Full Text] [Related]
4. A closed-loop artificial pancreas using model predictive control and a sliding meal size estimator.
Lee H; Buckingham BA; Wilson DM; Bequette BW
J Diabetes Sci Technol; 2009 Sep; 3(5):1082-90. PubMed ID: 20144421
[TBL] [Abstract][Full Text] [Related]
5. Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.
Magni L; Forgione M; Toffanin C; Dalla Man C; Kovatchev B; De Nicolao G; Cobelli C
J Diabetes Sci Technol; 2009 Sep; 3(5):1091-8. PubMed ID: 20144422
[TBL] [Abstract][Full Text] [Related]
6. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.
Kovatchev B; Cobelli C; Renard E; Anderson S; Breton M; Patek S; Clarke W; Bruttomesso D; Maran A; Costa S; Avogaro A; Dalla Man C; Facchinetti A; Magni L; De Nicolao G; Place J; Farret A
J Diabetes Sci Technol; 2010 Nov; 4(6):1374-81. PubMed ID: 21129332
[TBL] [Abstract][Full Text] [Related]
7. Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.
Grosman B; Dassau E; Zisser HC; Jovanovic L; Doyle FJ
J Diabetes Sci Technol; 2010 Jul; 4(4):961-75. PubMed ID: 20663463
[TBL] [Abstract][Full Text] [Related]
8. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
[TBL] [Abstract][Full Text] [Related]
9. Control to range for diabetes: functionality and modular architecture.
Kovatchev B; Patek S; Dassau E; Doyle FJ; Magni L; De Nicolao G; Cobelli C;
J Diabetes Sci Technol; 2009 Sep; 3(5):1058-65. PubMed ID: 20144419
[TBL] [Abstract][Full Text] [Related]
10. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR
Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976
[TBL] [Abstract][Full Text] [Related]
11. Manual Closed-Loop Insulin Delivery Using a Saddle Point Model Predictive Control Algorithm: Results of a Crossover Randomized Overnight Study.
Guilhem I; Penet M; Paillard A; Carpentier M; Esvant A; Lefebvre MA; Poirier JY
J Diabetes Sci Technol; 2017 Sep; 11(5):1007-1014. PubMed ID: 28677416
[TBL] [Abstract][Full Text] [Related]
12. Feasibility study of automated overnight closed-loop glucose control under MD-logic artificial pancreas in patients with type 1 diabetes: the DREAM Project.
Nimri R; Atlas E; Ajzensztejn M; Miller S; Oron T; Phillip M
Diabetes Technol Ther; 2012 Aug; 14(8):728-35. PubMed ID: 22853723
[TBL] [Abstract][Full Text] [Related]
13. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study.
Thabit H; Lubina-Solomon A; Stadler M; Leelarathna L; Walkinshaw E; Pernet A; Allen JM; Iqbal A; Choudhary P; Kumareswaran K; Nodale M; Nisbet C; Wilinska ME; Barnard KD; Dunger DB; Heller SR; Amiel SA; Evans ML; Hovorka R
Lancet Diabetes Endocrinol; 2014 Sep; 2(9):701-9. PubMed ID: 24943065
[TBL] [Abstract][Full Text] [Related]
14. Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes.
Kanderian SS; Weinzimer S; Voskanyan G; Steil GM
J Diabetes Sci Technol; 2009 Sep; 3(5):1047-57. PubMed ID: 20144418
[TBL] [Abstract][Full Text] [Related]
15. Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites.
Zisser H; Renard E; Kovatchev B; Cobelli C; Avogaro A; Nimri R; Magni L; Buckingham BA; Chase HP; Doyle FJ; Lum J; Calhoun P; Kollman C; Dassau E; Farret A; Place J; Breton M; Anderson SM; Dalla Man C; Del Favero S; Bruttomesso D; Filippi A; Scotton R; Phillip M; Atlas E; Muller I; Miller S; Toffanin C; Raimondo DM; De Nicolao G; Beck RW;
Diabetes Technol Ther; 2014 Oct; 16(10):613-22. PubMed ID: 25003311
[TBL] [Abstract][Full Text] [Related]
16. Model-based closed-loop glucose control in type 1 diabetes: the DiaCon experience.
Schmidt S; Boiroux D; Duun-Henriksen AK; Frøssing L; Skyggebjerg O; Jørgensen JB; Poulsen NK; Madsen H; Madsbad S; Nørgaard K
J Diabetes Sci Technol; 2013 Sep; 7(5):1255-64. PubMed ID: 24124952
[TBL] [Abstract][Full Text] [Related]
17. An integrated multivariable artificial pancreas control system.
Turksoy K; Quinn LT; Littlejohn E; Cinar A
J Diabetes Sci Technol; 2014 May; 8(3):498-507. PubMed ID: 24876613
[TBL] [Abstract][Full Text] [Related]
18. Artificial pancreas using a personalized rule-based controller achieves overnight normoglycemia in patients with type 1 diabetes.
Capel I; Rigla M; García-Sáez G; Rodríguez-Herrero A; Pons B; Subías D; García-García F; Gallach M; Aguilar M; Pérez-Gandía C; Gómez EJ; Caixàs A; Hernando ME
Diabetes Technol Ther; 2014 Mar; 16(3):172-9. PubMed ID: 24152323
[TBL] [Abstract][Full Text] [Related]
19. Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.
Buckingham BA; Forlenza GP; Pinsker JE; Christiansen MP; Wadwa RP; Schneider J; Peyser TA; Dassau E; Lee JB; O'Connor J; Layne JE; Ly TT
Diabetes Technol Ther; 2018 Apr; 20(4):257-262. PubMed ID: 29431513
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the accuracy and large inaccuracy of two continuous glucose monitoring systems.
Leelarathna L; Nodale M; Allen JM; Elleri D; Kumareswaran K; Haidar A; Caldwell K; Wilinska ME; Acerini CL; Evans ML; Murphy HR; Dunger DB; Hovorka R
Diabetes Technol Ther; 2013 Feb; 15(2):143-9. PubMed ID: 23256605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
